CVS Health's Caremark has become the second of the "Big Three" pharmacy benefit managers to reach a settlement with the Federal Trade Commission (FTC) in a lawsuit over insulin pricing. | CVS Health's ...

CVS Health said on Tuesday it has reached a proposed settlement agreement with the Federal Trade ‌Commission on insulin ...

The Federal Trade Commission sued the country’s three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin in order to reap millions ...

The Federal Trade Commission is suing the three largest prescription drug benefit managers (PBMs) for allegedly driving up insulin prices through anticompetitive and unfair rebating practices, ...

These pharmacy benefits managers, also known as PBMs, are either owned or connected to health insurance providers and are intended to facilitate negotiations with pharmaceutical manufacturers and ...

A settlement between CVS' pharmacy benefit manager and antitrust regulators would leave UnitedHealth as the sole holdout in high-profile suit.